Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.
| Image |  |
|---|---|
| Description | scientific article published on 18 January 2016 |
| Author/s | |
| Publication date | February 18, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |